Cite
HARVARD Citation
Fuller, S. et al. (n.d.). A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer. Journal for immunotherapy of cancer. p. . [Online].